Penumbra may gain market share in peripheral embolisation coils with Ruby XL
Penumbra has announced US Food and Drug Administration approval for its Ruby XL system, which includes three coils: the Ruby …
Post
-
-
GeneCentric advances precision oncology with new liquid biopsy platform
GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform, a diagnostic …
-
Neuspera secures FDA approval for urinary incontinence implantable
The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for treating urinary urge …
-
A new AI software to streamline patient consultations in the NHS
Beset by seemingly endless caseloads and responsibilities, within the UK National Health Service (NHS) and other healthcare systems globally, burnout …
-
PharmaSens and SiBionics to develop wearable insulin patch pump
Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that integrates the delivery …
-
EU imposes medical device procurement restrictions on Chinese firms
The European Commission (EC) will restrict Chinese companies from EU government purchases of medical devices exceeding €5m ($5.7m). The move comes …
-
GE HealthCare renews research partnership with Stanford Medicine
GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the advancement of total …
-
Altum Sequencing develops tool to monitor solid tumour treatment response
Cancer cell monitoring startup Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response …
-
J&J MedTech introduces new plates for VOLT fracture management platform
Johnson & Johnson (J&J) MedTech has launched two new plating systems for distal radius (wrist) and proximal humerus fractures for …
-
Invivoscribe’s LabPMM secures NYS approval for NPM1 MRD Assay
Invivoscribe's subsidiary, the Laboratory for Personalized Molecular Medicine (LabPMM), has secured New York State (NYS) approval for the NPM1 MRD …
-
BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory …
-
Exo lands FDA clearance for two AI lung disease ultrasound apps
Amid reports that Exo could pull in $100m from investors, the imaging startup has obtained 510(k) clearance from the US …
-
Grail reports positive outcomes from registrational study of Galleri test
Grail has reported encouraging top-line performance and safety outcomes from its registrational PATHFINDER 2 study’s pre-specified analysis of the Galleri …
-
GeneCentric secures $8m to launch liquid biopsy platform
GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and …
-
NHS England chair suggests England could learn from European health schemes
With the 10-year Health Plan on the horizon, the NHS could learn some tricks from France, Germany and the Nordics. At …
